Free Trial
NYSE:AVTR

Avantor Q2 2025 Earnings Report

Avantor logo
$13.57 -0.18 (-1.28%)
As of 01:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Avantor EPS Results

Actual EPS
N/A
Consensus EPS
$0.25
Beat/Miss
N/A
One Year Ago EPS
N/A

Avantor Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.67 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Avantor Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Friday, August 1, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Avantor Earnings Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Avantor Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avantor? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avantor and other key companies, straight to your email.

About Avantor

Avantor (NYSE:AVTR) (NYSE:AVTR) is a leading global provider of mission-critical products and services that support the life sciences and advanced technologies markets. The company offers a comprehensive portfolio of high-purity chemicals, reagents, consumables, and labware, alongside equipment and instrument solutions designed to enhance research, development, and production workflows. Avantor’s offerings span from basic laboratory supplies to sophisticated biopharma processing materials, catering to customers engaged in drug discovery, clinical research, diagnostics, and precision manufacturing.

Founded through the integration of legacy brands such as J.T. Baker and VWR, Avantor has evolved via strategic acquisitions and organic growth to become a unified platform serving more than 190 countries. Since its initial public offering in 2019, the company has continued to expand both its product lines and geographic footprint, investing in supply chain infrastructure and digital tools to improve accessibility and operational efficiency for customers worldwide.

Avantor’s operations are organized across three core business segments: life sciences solutions, focused on biopharma and clinical diagnostics; applied materials, serving semiconductor, electronics, and specialty chemicals markets; and institutional and government, which supports academic institutions, government research facilities, and industrial laboratories. These segments are underpinned by a global manufacturing and distribution network, ensuring reliable delivery of critical materials and services that enable customers to accelerate innovation and production timelines.

Headquartered in Radnor, Pennsylvania, Avantor is led by Chief Executive Officer Michael Stubblefield and a seasoned executive team with deep expertise in chemical manufacturing, life sciences, and supply chain management. The company emphasizes sustainability, digital transformation, and collaborative partnerships with customers to drive continuous improvement. With a focus on quality, regulatory compliance, and scientific excellence, Avantor aims to support the evolving needs of its diverse customer base and contribute to breakthroughs in health care, energy, and advanced materials.

View Avantor Profile

More Earnings Resources from MarketBeat